FREMONT, Calif., June 9 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Kumar Kastury, Ph.D., vice president of assay development, will provide a poster presentation on its SmartChip(TM) Real-Time PCR System at the Cambridge Healthcare Institute's Ninth Annual Beyond Genome conference. The conference will be held June 8-11, 2008, at the Fairmont Hotel in San Francisco.
WaferGen's poster presentation will be available on Wednesday, June 11th from 9:50 a.m. until 4:30 p.m. The presentation will include an overview of the company's novel whole genome, high-throughput SmartChip Real-Time PCR System, as well as data related to 100nL real-time PCR gene expression. The SmartChip Real-Time PCR System can perform tens of thousands of nano-scale quantitative PCR (qPCR) assays in a single run, combining the screening throughput of microarrays with the sensitivity of qPCR in a single step.
About WaferGen
WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip(TM) is being developed as the first whole genome, high throughput gene expression real-time polymerase chain reaction (PCR) platform and promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. WaferGen currently markets its SmartSlide(TM) family of products to companies and organizations involved in stem cell and cell biology research. SmartSlide(TM), which was launched in 2006, represents the first fluidics integrated micro-incubators enabling cell biology and stem cell research. Representative SmartSlide(TM) customers include Harvard University, Mayo Clinic, California Institute of Technology (CalTech), Abbott Labs, and the National Institutes of Health (NIH).
Contact:
Vida Communication (on behalf of WaferGen)
Stephanie Diaz (investors) Tim Brons (media)
415-675-7400 415-675-7402
sdiaz@vidacommunication.com tbrons@vidacommunication.com
SOURCE WaferGen Biosystems, Inc.
For further information: investors, Stephanie Diaz, +1-415-675-7400, sdiaz@vidacommunication.com, or media, Tim Brons, +1-415-675-7402, tbrons@vidacommunication.com, both of Vida Communication for WaferGen Biosystems, Inc.
© PR Newswire
